IndraLab

Statements


| 21

reach
"Pathogenic germline variants in the BRCA1-associated protein 1 (BAP1) gene cause a dominantly inherited tumor predisposition syndrome, BAP1-TPDS, in which MM is the second most common associated cancer."

reach
"BAP1-Tumor Predisposition Syndrome (TPDS) is caused by germline variants in BAP1 and predisposes to solid tumors."

reach
"Pathogenic germline variants in the BRCA1-Associated Protein 1 (BAP1) tumor suppressor gene cause a rare, life-threatening tumor predisposition syndrome (BAP1-TPDS, OMIM 614327) also known as BAP1 cancer syndrome as the majority of carriers develop malignancy [1, 2]."

reach
"Furthermore, BAP1 germline mutations cause a tumor predisposition syndrome inherited in an autosomal dominant pattern, which confers a higher risk for developing a spectrum of benign and malignant tumors , including pancreatic cancer ."

reach
"Altogether, these results define a clinical syndrome caused by rare germline missense BAP1 variants that alter chromatin remodeling through abnormal histone ubiquitination and lead to transcriptional dysregulation of developmental genes."

reach
"The presence of multiple BAP1-negative melanocytic neoplasms is a hallmark of familial cancer susceptibility syndrome caused by germline mutations in BAP1."

reach
"Additionally, melanoma risk is elevated in mixed cancer syndromes caused by mutations in PTEN, BRCA1, BRCA2, RB1, BAP1 and TP53 [56]."

reach
"(3)In previous studies, we found that heterozygous germline mutations in the BAP1 gene cause the BAP1 Cancer Syndrome, characterized by a high incidence of mesothelioma (4–9)."

reach
"BAP1 tumor predisposition syndrome is caused by pathogenic germline variants in the BAP1 tumor suppressor gene and characterized by a predisposition to various tumors including meningioma."

reach
"Melanoma predisposition syndromes caused by pathogenic variants in POT1 and BAP1 are more recently described, and both are associated with Spitzoid tumors."

reach
"Familial cancer predisposition syndrome caused by germline mutations in BAP1 is inherited in an autosomal dominant pattern."

reach
"Germline mutations of the deubiquitinase BRCA1-associated protein 1 (BAP1) lead to the "BAP1 cancer syndrome" characterized by development of cancers."

reach
"Germline loss-of-function variants in the BRCA1-associated protein 1 gene (BAP1) cause an autosomal dominant tumor predisposition syndrome, with most such variants generating frameshift or truncating alleles, yet >1,000 missense variants have been clinically observed to date."

reach
"Screening of genealogies from affected families led to the discovery of an inherited cancer syndrome caused by BAP1 germline mutations [68,69]."

reach
"It is very intriguing to ask whether BAP1 expression mediated by G-quadruplex formation contributes to this syndrome."

reach
"A rare familial syndrome at risk for ccRCC is caused by germline mutations in BAP1 ."

reach
"Germline pathogenic mutations in the tumor suppressor gene BRCA1-associated protein-1 (BAP1) lead to BAP1 tumor predisposition syndrome (BAP1-TPDS) [6], which is characterized by high susceptibility to several tumor types, mainly melanoma (especially uveal), mesothelioma, renal cell carcinoma, and basal cell carcinoma (Table 2)."

reach
"BAP1 germline mutations underlie a rare, autosomal dominant tumour predisposition syndrome that is most commonly associated with (in order of decreasing frequency) atypical Spitz tumours, uveal melano[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Germline mutations in BAP1 are known to cause a tumor predisposition syndrome, which is accompanied by the risk of early onset of several malignancies, such as (uveal) melanoma, renal cancer, and PeM."

reach
"BIMTs can occur as a sporadic lesion or, less commonly, in the setting of an autosomal dominant cancer susceptibility syndrome caused by a BAP1 germline inactivating mutation."

reach
"Histone deacetylase inhibitors may reverse this phenomenon 8. In addition, a comprehensive understanding of pathway changes caused by BAP1 mutations may also be useful in filtering potential therapeutic targets.Previous studies revealed that in ccRCC patients, BAP1 has a high mutation rate in somatic cells 7, 10 and BAP1 germline mutations will lead to a hereditary renal carcinoma syndrome."